Inventor · disambiguated record
Matthew Perry
Also filed as: PERRY MATTHEW · PERRY MATTHEW W D · PERRY MATTHEW WILLIAM DAMPIER
18 granted patents·17 pending applications·253 citations·filing 1997–2021
93Inventor score
Top patents by PatentIndex Score
35 records- 0193US6342601B1CompoundsASTRAZENECA AB·Filed 1999·Granted Jan 29, 2002·122 cites·13 claims
- 0287US6903085B1Substituted piperidine compounds useful as modulators of chemokine receptor activityASTRAZENECA AB·Filed 2000·Granted Jun 7, 2005·37 cites·6 claims
- 0383US7265227B2Piperidine derivatives useful as modulators of chemokine receptor activityASTRAZENECA AB·Filed 2002·Granted Sep 4, 2007·22 cites·11 claims
- 0480US7307090B2Piperidine derivatives useful as modulators of chemokine receptor activityASTRAZENECA AB·Filed 2002·Granted Dec 11, 2007·15 cites·9 claims
- 0580US6342502B1Thieno[2,3-d]pyrimidine diones and their use in the treatment of reversible obstructive airways diseasesASTRAZENECA AB·Filed 2000·Granted Jan 29, 2002·14 cites·19 claims
- 0674US6958350B2Chemical compoundsASTRAZENECA AB·Filed 2002·Granted Oct 25, 2005·7 cites·8 claims
- 0773US6469014B1Thieno[2,3-d] pyrimidinediones, their preparation and use in therapyASTRAZENECA AB·Filed 2001·Granted Oct 22, 2002·6 cites·19 claims
- 0872US7517989B2Piperidine derivatives useful as modulators of chemokine receptor activityASTRAZENECA AB·Filed 2003·Granted Apr 14, 2009·5 cites·6 claims
- 0971US6306863B1Pyrrolo[3,4-d]pyrimidinone derivatives and their use as medicamentsASTRAZENECA AB·Filed 2000·Granted Oct 23, 2001·3 cites·11 claims
- 1067US7495013B2Chemical compoundsASTRAZENECA AB·Filed 2004·Granted Feb 24, 2009·4 cites·19 claims
- 1161US6890923B2CompoundsASTRAZENECA AB·Filed 2002·Granted May 10, 2005·1 cites·11 claims
- 1259US6300334B1Thieno[2,3-d]pyrimidine-2,4-dionesASTRAZENECA AB·Filed 1999·Granted Oct 9, 2001·17 cites·12 claims
- 1358US2009069325A1Piperidine Derivatives Useful as Modulators of Chemokine Receptor ActivityASTRAZENECA AB·Filed 2008·Application pending·0 cites
- 1456US2009118513A1Chemical CompoundsASTRAZENECA AB·Filed 2009·Application pending·0 cites
- 1553US2021047312A1Inhibitors of phosphatidylinositol 3-kinase gammaASTRAZENECA AB·Filed 2020·Application pending·0 cites
- 1652US10961236B2(S)-2-(1-cyclopropylethyl)-5-(4-methyl-2-((6-(2-oxopyrrolidin-1-yl)pyridin-2-yl)amino) thiazol-5-yl)-7-(methylsulfonyl)isoindolin-1-one as a phosphatidylinositol 3-kinase inhibitorASTRAZENECA AB·Filed 2017·Granted Mar 30, 2021·0 cites·6 claims
- 1750US2023374007A1Compounds and their use in treating cancerASTRAZENECA AB·Filed 2021·Application pending·0 cites
- 1847US10858355B2Inhibitors of phosphatidylinositol 3-kinase gammaASTRAZENECA AB·Filed 2017·Granted Dec 8, 2020·0 cites·4 claims
- 1947US6770646B2Substituted fused pyridazinone compounds; composition and use thereofASTRAZENECA AB·Filed 2001·Granted Aug 3, 2004·0 cites·13 claims
- 2046US8314127B2Piperidine derivativesAUSTIN TALBIR·Filed 2006·Granted Nov 20, 2012·0 cites·3 claims
- 2146US2009197914A1Piperidine Derivatives, Their Process for Preparation, Their Use as Therapeutic Agents and Pharmaceutical Compositions Containing ThemCAGE PETER·Filed 2007·Application pending·0 cites
- 2245US2005250792A1Substituted piperidine compounds useful as modulators of chemokine receptor activityTHOM STEPHEN·Filed 2005·Application pending·0 cites
- 2345US2009023733A1Piperidine Derivatives, Their Process for Preparation, Their Use as Therapeutic Agents and Pharmaceutical Compositions Containing ThemCAGE PETER·Filed 2007·Application pending·0 cites
- 2445US2006281726A1Piperidine derivatives for the treatment of chemokine or h1 mediated disease stateLUCKHURST CHRISTOPHER·Filed 2004·Application pending·0 cites
- 2544US2008275084A1Piperidines for the Treatment of Chemokine Mediated DiseasesASTRAZENECA AB·Filed 2006·Application pending·0 cites
- 2644US2008200505A1Piperidines for the Treatment of Chemokine Mediated DiseasesASTRAZENECA AB·Filed 2006·Application pending·0 cites
- 2744US2013023562A1Novel piperidine derivativesASTRAZENECA AB·Filed 2012·Application pending·0 cites
- 2844US2006040984A1Novel piperidine derivatives for use in the treatment of chemokine medicated disease statesLUCKHURST CHRISTOPHER·Filed 2003·Application pending·0 cites
- 2943US2009012125A1Piperidine Derivatives, Their Process for Preparation, Their Use as Therapeutic Agents and Pharmaceutical Compositions Containing ThemCAGE PETER·Filed 2007·Application pending·0 cites
- 3041US2009253929A1Chemical CompoundsASTRAZENECA AB·Filed 2005·Application pending·0 cites
- 3141US2007276141A1Preparation of Pharmaceutical Salts of [1,4] - BipiperidineELSE HOWARD·Filed 2004·Application pending·0 cites
- 3240US6984644B2Treatment of skin disorders using thieno[2,3-D]pyrimidinedionesASTRAZENECA AB·Filed 2002·Granted Jan 10, 2006·0 cites·19 claims
- 3340US2006264463A1Chemical compoundsLUCKHURST CHRISTOPHER·Filed 2004·Application pending·0 cites
- 3439US2008262037A1Piperidine Derivatives for the Treatment of Chemokine Mediated DiseaseASTRAZENECA AB·Filed 2005·Application pending·0 cites
- 3528US5935956APyridazine compoundsASTRA PHARMA PROD·Filed 1997·Granted Aug 10, 1999·0 cites·10 claims
Join the waitlist — get patent alerts
Get an alert when Matthew Perry files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →